CD8A and COVID-19: Breton et al [20] described a reduced frequency of CD4+ T cells and an increased frequency of CD8+ T cells in patients at 1.3 months after COVID-19 compared to healthy controls and compared to 6.1 months after COVID-19 in a larger patient cohort.